Biblio

Export 106 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is L  [Clear All Filters]
2021
C. G. Schwarz, Knopman, D. S., Ramanan, V. K., Lowe, V. J., Wiste, H. J., Cogswell, P. M., Utianski, R. L., Senjem, M. L., Gunter, J. R., Vemuri, P., Petersen, R. C., and Jack, C. R., “Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual.”, J Alzheimers Dis, vol. 85, no. 1, pp. 59-64, 2021.
J. M. Cuttler, Abdellah, E., Goldberg, Y., Al-Shamaa, S., Symons, S. P., Black, S. E., and Freedman, M., “Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1119-1128, 2021.
T. Xiao, Wijnant, S. R. A., Licher, S., Terzikhan, N., Lahousse, L., M Ikram, K., Brusselle, G. G., and M Ikram, A., “Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 82, no. 2, pp. 621-630, 2021.
2020
N. Schultz, Byman, E., and Wennström, M., “Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1201-1209, 2020.
Y. Gao, Zhang, N., Lv, C., Li, N., Li, X., and Li, W., “lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 1, pp. 85-98, 2020.
J. Hyun Han, Lee, H. - J., Han, J. Won, Suh, S. Wan, Lee, J. Ri, Byun, S., Kim, K. Suh, Kim, S. Yeol, Lee, J. - T., Yoo, E., Chang, N. - H., Kim, T. Hui, and Kim, K. Woong, “Loss of Functional Dentition is Associated with Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1313-1320, 2020.
2019
S. M. Barton, Janve, V. A., McClure, R., Anderson, A., Matsubara, J. A., Gore, J. C., and Pham, W., “Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.”, J Alzheimers Dis, vol. 67, no. 2, pp. 503-513, 2019.
A. L. La, Walsh, C. M., Neylan, T. C., Vossel, K. A., Yaffe, K., Krystal, A. D., Miller, B. L., and Karageorgiou, E., “Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers.”, J Alzheimers Dis, vol. 67, no. 3, pp. 911-921, 2019.
2018
F. Vecchio, Miraglia, F., Quaranta, D., Lacidogna, G., Marra, C., and Rossini, P. Maria, “Learning Processes and Brain Connectivity in A Cognitive-Motor Task in Neurodegeneration: Evidence from EEG Network Analysis.”, J Alzheimers Dis, vol. 66, no. 2, pp. 471-481, 2018.
J. Krell-Roesch, Feder, N. T., Roberts, R. O., Mielke, M. M., Christianson, T. J., Knopman, D. S., Petersen, R. C., and Geda, Y. E., “Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 63, no. 1, pp. 149-155, 2018.
L. Yu, Liu, Y., Jin, Y., Cao, X., Chen, J., Jin, J., Gu, Y., Bao, X., Ren, Z., Xu, Y., and Zhu, X., “Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1411-1424, 2018.
L. Gao, Jiang, Y., Wei, S., Shang, S., Li, P., Chen, C., Dang, L., Wang, J., Huo, K., Deng, M., Wang, J., Zhang, R., and Qu, Q., “The Level of Plasma Amyloid-β40 Is Correlated with Peripheral Transport Proteins in Cognitively Normal Adults: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 951-961, 2018.
F. Ferreira de Oliveira, de Almeida, S. Soares, Chen, E. Suchi, Smith, M. Cardoso, Naffah-Mazzacoratti, Mda Graça, and Bertolucci, P. Henrique F., “Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1283-1299, 2018.
S. Cosentino, Devanand, D., and Gurland, B., “A Link between Subjective Perceptions of Memory and Physical Function: Implications for Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1387-1398, 2018.
M. Ihara and Washida, K., “Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.”, J Alzheimers Dis, vol. 62, no. 1, pp. 61-72, 2018.
R. M. Ahmed, Highton-Williamson, E., Caga, J., Thornton, N., Ramsey, E., Zoing, M., Kim, W. Scott, Halliday, G. M., Piguet, O., Hodges, J. R., I Farooqi, S., and Kiernan, M. C., “Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition.”, J Alzheimers Dis, vol. 61, no. 2, pp. 773-783, 2018.
P. Mecocci, Boccardi, V., Cecchetti, R., Bastiani, P., Scamosci, M., Ruggiero, C., and Baroni, M., “A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1319-1335, 2018.
C. M. Burns, Kaszniak, A. W., Chen, K., Lee, W., Bandy, D. J., Caselli, R. J., and Reiman, E. M., “Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.”, J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.
D. Wang, Schultz, T., Novak, G. P., Baker, S., Bennett, D. A., and Narayan, V. A., “Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.”, J Alzheimers Dis, vol. 62, no. 2, pp. 855-865, 2018.
G. Cuberas-Borrós, Roca, I., Boada, M., Tárraga, L., Hernandez, I., Buendia, M., Rubio, L., Torres, G., Bittini, Á., Guzmán-de-Villoria, J. A., Pujadas, F., Torres, M., Núñez, L., Castell, J., and Páez, A., “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
H. Wang, Stewart, T., Toledo, J. B., Ginghina, C., Tang, L., Atik, A., Aro, P., Shaw, L. M., Trojanowski, J. Q., Galasko, D. R., Edland, S., Jensen, P. H., Shi, M., and Zhang, J., “A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1541-1553, 2018.
S. P. Salloway, Sperling, R., Fox, N. C., Sabbagh, M. N., Honig, L. S., Porsteinsson, A. P., Rofael, H., Ketter, N., Wang, D., Liu, E., Carr, S., Black, R. S., and H Brashear, R., “Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 689-707, 2018.
L. Boson Gambogi, Guimarães, H. Cerqueira, de Souza, L. Cruz, and Caramelli, P., “Long-Term Severe Mental Disorders Preceding Behavioral Variant Frontotemporal Dementia: Frequency and Clinical Correlates in an Outpatient Sample.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1577-1585, 2018.
A. Sen, Nelson, T. J., Alkon, D. L., and Hongpaisan, J., “Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1173-1189, 2018.
J. F. Quinn, “Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.”, J Alzheimers Dis, vol. 64, no. s1, pp. S33-S39, 2018.

Pages